These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16153869)

  • 1. [Platelet-washing solution optimization].
    Grossin E; Chamfly V
    Transfus Clin Biol; 2005 Oct; 12(4):319-30. PubMed ID: 16153869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.
    Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A
    Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
    Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
    Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of additive solutions on platelet biochemistry.
    Holme S
    Blood Cells; 1992; 18(3):421-30; discussion 431-4. PubMed ID: 1286196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high-yield thrombocytapheresis on the quality of platelet products.
    Julmy F; Ammann RA; Mansouri Taleghani B; Fontana S; Hirt A; Leibundgut K
    Transfusion; 2008 Mar; 48(3):442-50. PubMed ID: 18067508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of Haemonetics MCS+ apheresis platelet concentrates treated with photochemical pathogen inactivation following plasma volume reduction using the INTERCEPT Preparation Set.
    Isola H; Kientz D; Aleil B; Laeuffer P; Weil J; Wiesel ML; Laforêt M; Lin L; Mayaudon V; Cazenave JP
    Vox Sang; 2006 Feb; 90(2):128-30. PubMed ID: 16430671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma-depleted platelet concentrates prepared with a new washing solution.
    Shimizu T; Shibata K; Kora S
    Vox Sang; 1993; 64(1):19-23. PubMed ID: 8447117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
    Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
    Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet additive solutions: a future perspective.
    van der Meer PF
    Transfus Clin Biol; 2007 Dec; 14(6):522-5. PubMed ID: 18420439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of a closed-system cell processor (ACP215) for automated preparation of washed platelet concentrates.
    Oikawa S; Sasaki D; Kikuchi M; Sawamura Y; Itoh T
    Vox Sang; 2012 Feb; 102(2):110-5. PubMed ID: 21770954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which are the parameters to be controlled in platelet concentrates in order that they may be offered to the medical profession as a standardized product with specific properties?
    Vox Sang; 1981 Feb; 40(2):115-26. PubMed ID: 7233883
    [No Abstract]   [Full Text] [Related]  

  • 12. Automated preparation of platelet concentrates from pooled buffy coats using the Gambro OrbiSac system.
    Gulliksson H; Sjödin A; Sandgren P; Vesterinen M; Larsson S; Diedrich B
    Transfus Apher Sci; 2003 Aug; 29(1):11-2. PubMed ID: 12877886
    [No Abstract]   [Full Text] [Related]  

  • 13. Washing of platelets can be fully automated using a closed-system cell processor and BRS-A platelet additive solution.
    Oikawa S; Minegishi M; Endo K; Kawashima W; Suzuki K; Shimizu H
    Vox Sang; 2016 Nov; 111(4):437-440. PubMed ID: 27509576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.
    Ringwald J; Haager B; Krex D; Zimmermann R; Strasser E; Antoon M; De Schrijver E; Eckstein R
    Transfusion; 2006 Jun; 46(6):942-8. PubMed ID: 16734810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of irradiation on platelets in M-sol additive solution with 30 percent residual plasma.
    Hirayama J; Kojima S; Akino M; Fujihara M; Kanai H; Homma C; Azuma H; Yamamoto S; Kato T; Ikeda H
    Transfusion; 2009 Apr; 49(4):813-5. PubMed ID: 19335379
    [No Abstract]   [Full Text] [Related]  

  • 16. Extended storage of platelets in SSP platelet additive solution.
    Hornsey VS; McColl K; Drummond O; McMillan L; Morrison A; Morrison L; MacGregor IR; Prowse CV
    Vox Sang; 2006 Jul; 91(1):41-6. PubMed ID: 16756600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet transfusion.
    Machin SJ; Kelsey H; Seghatchian MJ; Warwick R; Mackie IJ
    Thromb Haemost; 1995 Jul; 74(1):246-52. PubMed ID: 8578466
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study of plateletpheresis using Baxter CS 3000 plus and Haemonetics MCS 3P.
    Patel AP; Kaur A; Patel V; Patel N; Shah D; Kanvinde S; Prajapati S; Patel H; Rathod D; Adesara R; Rani S
    J Clin Apher; 2004; 19(3):137-41. PubMed ID: 15493051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suitability of measurement of swirling as a marker of platelet shape change in concentrates stored for transfusion.
    Mathai J; Resmi KR; Sulochana PV; Sathyabhama S; Baby Saritha G; Krishnan LK
    Platelets; 2006 Sep; 17(6):393-6. PubMed ID: 16973500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of platelet in vitro properties during 7-day storage in M-sol with a 30-hour interruption of agitation.
    Wagner SJ; Myrup A; Awatefe H; Thompson-Montgomery D; Hirayama J; Skripchenko A
    Transfusion; 2008 Dec; 48(12):2501-607. PubMed ID: 18764828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.